Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Nodetrip (previously Xeristar)

Withdrawn

Human

Details

EMA number	EMEA/H/C/000573
ATC code	N06AX21
Authorisation	17 December 2004
Withdrawn	12 May 2021
Revision	32

Therapeutic indication

Treatment of major depressive disorder; Treatment of diabetic peripheral neuropathic pain; Treatment of generalised anxiety disorder; Xeristar is indicated in adults.

MeSH: Anxiety Disorders;Depressive Disorder, Major;Diabetic Neuropathies

Group: Psychoanaleptics

Active substances

Marketing Authorisation Holder

Esteve Pharmaceuticals, S.A.

Timeline

Filter by authority:

Nodetrip (previously Xeristar) withdrawn

12 May 2021

withdrawnregulatory

Nodetrip (previously Xeristar) authorised

17 Dec 2004

authorisedregulatory

Nodetrip (previously Xeristar) | uMedical